Edwards Lifesciences (EW) insider trading

By person

27 insiders · 966 transactions

7.7×

Mr. Zovighian holds 7.7 times base salary in stock. $9.23M of shares against $1.19M in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Zovighian last reported holding, valued at $85.65, the price Common Stock was last bought or sold at on the open market here, on 8 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Michael A Mussallem

Director

—

$358.82M (292) scheduled

−$358.82M

4,042,863

0.7014%

$346.27M

+36.1%

Donald E Bobo Jr

CVP,Strategy/Corp Development

—

$117.14M (182) scheduled

−$117.14M

121,409

0.0211%

$10.40M

−41.5%

Scott B. Ullem

CVP, Chief Financial Officer

—

$75.91M (69) scheduled

−$75.91M

313,058

0.0543%

$26.81M

+20.8%

Larry L Wood

Global President TAVR & Surg

—

$72.46M (91) scheduled

−$72.46M

207,066

0.0359%

$17.74M

+22.1%

Huimin Wang

CVP, Japan & Intercontinental

—

$46.90M (79) scheduled

−$46.90M

99,381

0.0172%

$8.51M

−29.1%

Catherine M. Szyman

CVP, Critical Care

$1.07M (2)

$43.22M (84) scheduled

−$42.15M

81,287

0.0141%

$6.96M

+51.7%

Jean-Luc M Lemercier

CVP, EMEACLA and JAPAC

—

$22.66M (30) scheduled

−$22.66M

184,686

0.0320%

$15.82M

+38.7%

Bernard J Zovighian

CEO

$49.75K (1)

$14.21M (18) scheduled

−$14.16M

107,761

0.0187%

$9.23M

+252.5%

Robert W.a. Sellers

SVP, Corporate Controller

—

$13.66M (18) scheduled

−$13.66M

37,490

0.0065%

$3.21M

−19.7%

Daveen Chopra

CVP, TMTT, Surgical & IHFM

—

$11.08M (24) scheduled

−$11.08M

43,926

0.0076%

$3.76M

+368.9%

Patrick B Verguet

CVP, Europe

—

$9.87M (11) scheduled

−$9.87M

129,137

0.0224%

$11.06M

0.0%

William J Phd Link

Director

—

$7.03M (8)

−$7.03M

16,071

0.0028%

$1.38M

−72.7%

Kieran Gallahue

Director

$524.20K (2)

$3.84M (2) scheduled

−$3.32M

71,534

0.0124%

$6.13M

+131.0%

Martha H. Marsh

Director

—

$3.10M (1) scheduled

−$3.10M

31,880

0.0055%

$2.73M

+76.6%

Heisz Leslie Stone

Director

—

$2.92M (6) scheduled

−$2.92M

34,199

0.0059%

$2.93M

+166.2%

Daniel J. Lippis

Cvp, Tavr

—

$1.99M (26) scheduled

−$1.99M

40,034

0.0069%

$3.43M

+116.4%

Wayne Markowitz

Cvp, Japac

—

$1.11M (7) scheduled

−$1.11M

19,371

0.0034%

$1.66M

+8,591%

Schack Wesley W Von

Director

—

$968.25K (4)

−$968.25K

9,737

0.0017%

$833.97K

−7.8%

Nicholas J Valeriani

Director

$168.35K (1)

$698.75K (1) scheduled

−$530.41K

84,423

0.0146%

$7.23M

+140.0%

Steven R Loranger

Director

—

$438.58K (1) scheduled

−$438.58K

8,997

0.0016%

$770.59K

—

Annette Bruls

Cvp, Emeacla

—

$237.91K (1)

−$237.91K

17,984

0.0031%

$1.54M

+122.6%

Andrew M. Dahl

SVP, Corporate Controller

—

$98.39K (2)

−$98.39K

14,615

0.0025%

$1.25M

+493.4%

Theodora Mistras

CVP, Chief Financial Officer

—

99,920

0.0173%

$8.56M

—

Paul A Laviolette

Director

—

17,552

0.0030%

$1.50M

—

Leslie C. Davis

Director

—

9,834

0.0017%

$842.28K

—

David T Feinberg

Director

—

9,087

0.0016%

$778.30K

—

Ramona Sequeira

Director

—

6,779

0.0012%

$580.62K

—

Edwards Lifesciences

What the insiders did Mostly scheduled

By person